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Abstract
Background: Outcome quality indicators are rarely used to evaluate mental health services because most
jurisdictions lack clinical data systems to construct indicators in a meaningful way across mental health providers.
As a result, important information about the effectiveness of health services remains unknown. This study examined
the feasibility of developing mental health quality indicators (MHQIs) using the Resident Assessment Instrument -
Mental Health (RAI-MH), a clinical assessment system mandated for use in Ontario, Canada as well as many other
jurisdictions internationally.
Methods: Retrospective analyses were performed on two datasets containing RAI-MH assessments for 1,056
patients from 7 facilities and 34,788 patients from 70 facilities in Ontario, Canada. The RAI-MH was completed by
clinical staff of each facility at admission and follow-up, typically at discharge. The RAI-MH includes a breadth of
information on symptoms, functioning, socio-demographics, and service utilization. Potential MHQIs were derived
by examining the empirical patterns of improvement and incidence in depressive symptoms and cognitive
performance across facilities in both sets of data. A prevalence indicator was also constructed to compare restraint
use. Logistic regression was used to evaluate risk adjustment of MHQIs using patient case-mix index scores derived
from the RAI-MH System for Classification of Inpatient Psychiatry.
Results: Subscales from the RAI-MH, the Depression Severity Index (DSI) and Cognitive Performance Scale (CPS),
were found to have good reliability and strong convergent validity. Unadjusted rates of five MHQIs based on the
DSI, CPS, and restraints showed substantial variation among facilities in both sets of data. For instance, there was a
29.3% difference between the first and third quartile facility rates of improvement in cognitive performance. The
case-mix index score was significantly related to MHQIs for cognitive performance and restraints but had a relatively
small impact on adjusted rates/prevalence.
Conclusions: The RAI-MH is a feasible assessment system for deriving MHQIs. Given the breadth of clinical content
on the RAI-MH there is an opportunity to expand the number of MHQIs beyond indicators of depression, cognitive
performance, and restraints. Further research is needed to improve risk adjustment of the MHQIs for their use in
mental health services report card and benchmarking activities.
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Background
Quality indicators support accountability for funding,
delivery, effectiveness, and improvement of health ser-
vices [1,2]. As such, numerous quality indicator initia-
tives for mental healthcare are evident internationally
[3-5] with a large degree of heterogeneity in the types,
sophistication, and utility of indicators across countries
[6]. Most reporting infrastructures for quality acknow-
ledge the need for structure, process, and outcome indi-
cators [7]. Process indicators are those most commonly
used [2,4] and have been the primary focus of bench-
marking quality of mental healthcare to date [8,9].
Process indicators consider issues such as safety, accessi-
bility, appropriateness, and timeliness of treatments and
services[10]. The use of outcome indicators of mental
healthcare, particularly those focused on clinical status,
is limited even though there is well documented need
[11-13]. Research on mental health outcomes is exten-
sive, but only a handful of studies have used outcome
measures to compare quality among providers [3,14-18].
Outcome indicators provide information about the ef-
fectiveness of mental health services that, when used in
combination with process indicators, can provide infor-
mation about the link between service delivery and ef-
fectiveness [19,20].
The utility of outcome indicators for measuring the
quality of mental health services relies on the availability
of clinical data sources that are common across provi-
ders. In addition to constructing outcome indicators,
clinical data are needed for appropriate case mix adjust-
ment [14,15,21-24]. When patient characteristics are
strongly related to an outcome of interest and are un-
equally distributed among providers, comparisons of out-
comes may favor providers who have a favorable case mix
(i.e., a high number of patients who have “less severe”
conditions or illness). Case mix, or risk, adjustment is best
applied using person level clinical characteristics [23];
however, other than sociodemographic (e.g., age, sex) and
diagnostic information, these data have not been routinely
available.
There have been several calls for a common mental
health clinical data source that includes patient charac-
teristics, service utilization, and outcomes to support
care delivery and quality measurement of inpatient
psychiatry [12,25,26]. Responding to similar calls, the
Ontario Ministry of Health and Long Term Care
(MoHLTC) implemented the Resident Assessment In-
strument for Mental Health (RAI-MH; called the
interRAI MH internationally) [27,28] for use in all fa-
cilities with adult psychiatric hospitals/units beginning
in October 2005. The RAI-MH is the primary assess-
ment system used for the Ontario Mental Health
Reporting System (OMHRS) of the Canadian Institute
for Health Information (CIHI) (www.cihi.ca/omhrs).
OMHRS produces quarterly reports on patient character-
istics, case mix, care needs, outcomes, and quality to all
hospitals with mental health beds in Ontario. The inter-
RAI Mental Health has also been implemented in other
provinces (e.g., Newfoundland and Labrador, Manitoba)
and internationally (e.g., Iceland, Finland). Compatible
interRAI systems have been implemented in other health
sectors in the United States, Canada, and internationally
[29-32].
The RAI-MH is part of a suite of assessment systems
available for almost every health sector. The RAI-MH
and other interRAI assessments include applications for
care planning, case-mix, outcomes, and quality measure-
ment [28]. Most interRAI quality indicator research, to
date, has focused on long term care [33-36], home care
[37,38], and post-acute care [39]. A set of 35 Mental
Health Quality Indicators (MHQIs) was developed based
on a previous version of the RAI-MH [40]. The initial
MHQIs included outcome and process indicators of
emotional, behaviour, and cognitive patterns, nutrition/
eating, physical functioning, clinical management, res-
traints, sexual violence, and accidents. At the time of de-
velopment, longitudinal data were not available to assess
the utility of the initial MHQIs because the MoHLTC
had not yet implemented the RAI-MH. When the in-
strument was implemented, a new version was used that
no longer included items to support all domains in the
original MHQIs. The current implementation does in-
clude data that is collected at multiple points in time
during an inpatient stay.
The purpose of this study is to evaluate the feasibility
of using the current version of the RAI-MH to derive
MHQIs. Choosing several domains from the initial
MHQIs, this study will examine RAI-MH content to de-
velop several new MHQIs and explore the utility of
these MHQIs for identifying variability across mental
health settings. For each MHQI, this study will also
examine the utility of a RAI-MH case-mix index variable
for risk adjustment. The goal of this study is to intro-
duce the concept and potential utility of the MQHIs
based on the RAI-MH for carrying out quality measure-
ment of inpatient mental health services.
Methods
Data
Retrospective analyses were performed on two RAI-
MH datasets representing inpatients of mental health
facilities in Ontario, Canada. The first dataset (pilot
data) was used to initially derive several MHQIs. The
pilot data included assessments for 1,056 patients from
a RAI-MH pilot study in seven volunteer facilities in
Ontario conducted between November, 2004 and April,
2005. Clinical staff at participating facilities who received
three days of RAI-MH training completed RAI-MH
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assessments on consecutive admissions of adults aged 18
years and older. For each patient, an admission assessment
was completed after the third day of stay and an additional
assessment was completed at discharge. The admission as-
sessment was completed after the third day of stay be-
cause a number of RAI-MH items are based on 72 hour
observation periods. De-identified data were submitted by
each facility to the research team at the University of
Waterloo. This protocol received approval from the Uni-
versity Of Waterloo Office of Research Ethics and the re-
search ethics boards of participating facilities, where
applicable.
The second dataset included 34,788 episodes of care
for persons who had two complete RAI-MH assessments
submitted to CIHI between October, 2005 and March
31, 2007. Under provincial implementation, the RAI-
MH is completed at admission and discharge for each
person and submitted quarterly by each facility to CIHI.
Data quality checks and reports are completed by the
OMHRS team at CIHI and communicated to facilities.
These reports include a review of item non-response,
data accuracy, coding errors, and other data quality
issues (a full overview of data quality can be found at
www.cihi.ca/omhrs). Assessments with errors are re-
jected and returned to hospitals for correction. Through
a data sharing agreement, CIHI sent a copy of the de-
identified data to interRAI through the University of
Waterloo.
Measures
The RAI-MH assesses domains including demographics,
mental and physical health symptoms, substance use,
behaviors, and service utilization, as well as social, voca-
tional, cognitive, and physical functioning [28,41]. Taking
about an hour to complete for an average person, the
RAI-MH is completed by clinical staff overseeing the
treatment of the person based on interview, observation,
and discussion with other members of the care team.
The implementation in Ontario hospitals of the RAI-
MH was supported by extensive training managed and
delivered by CIHI. Each hospital contributing RAI-MH
is assigned at least one “RAI Coordinator”, typically a
clinical staff member of the hospital who provides on-
going RAI-MH support and training to clinicians. The
CIHI also provides ongoing training and support though
face to face training sessions, teleconferences, webcasts,
and ad hoc email or telephone support. Information
from the RAI-MH contributes to the global clinical as-
sessment of the person and is included in clinical docu-
mentation. Based on provincial mandate, the completion
rate of the RAI-MH in routine care in Ontario is 100%
for all persons admitted for at least 72 hours (a different
assessment is completed for persons staying less than 72
hours). In reliability studies, the average agreement was
83% for all RAI-MH items [41] and the average weighted
Kappa for all RAI-MH items was 0.70 [42], considered
by Landis and Koch [43] to be “substantial agreement”.
Variables used to construct the MHQIs
Three domains were chosen for potential MHQIs: De-
pressive symptoms, cognitive performance, and restraints.
These domains were chosen based on their relevance to
rehabilitation of severe mental illness [44] and the emer-
gence of restraint reduction as a leading focus of patient
safety in mental health services [45]. A number of sub-
scales and items embedded in the RAI-MH were consid-
ered for derivation of MHQIs. For depressive symptoms,
derivation was based on the Depression Severity Index
(DSI). The DSI is a scale that sums responses from the
following five items: Sad or pained facial expressions,
made negative statements, self-depreciation, expressions
of guilt/shame, hopeless. Each item is scored based on
observed frequency over the prior 3 days from 0 (not
present) to 3 (present daily) creating a total DSI score that
ranges from 0 to 15. In pilot testing with 1000 patients
from ten Ontario hospitals, the DSI was found to have
good internal consistency (Cronbach’s alpha = 0.81) and
it was strongly associated with indicators of suicidality
(e.g., has a suicide plan)[unpublished data, JPH]. Cogni-
tive Performance was assessed using the Cognitive Per-
formance Scale (CPS). The CPS is based on a decision
tree algorithm that includes items assessing daily deci-
sion-making, short-term memory, ability to make self-
understood, and self-performance in eating. The CPS
ranges from 0 to 6 identifying persons with intact (0), bor-
derline intact (1), mild (2), moderate (3), moderate-severe
(4), severe (5), or very severe (6) cognitive performance
[46]. The CPS has been found to correlate with the Mini-
Mental State Examination [47] and the Montreal Cognitive
Assessment [48] among persons receiving inpatient men-
tal health services [49]. For restraints, the RAI-MH in-
cludes items assessing the number of times in the prior
3-days a person experienced the following restraints:
mechanical, chair that prevents rising, and physical/
manual restraint by staff. A restraint variable was created
and coded as yes (1) if any of these items were coded as
present.
Calculation of MHQIs
One objective of the study was to explore how the items
and sub-scales described above could be used to define
quality indicators at the facility level for comparison.
The initial MHQIs focused on patterns of change in de-
pression and cognitive impairment based on rates of im-
provement and incidence. Restraint use was assessed
based on prevalence in the three days prior to assess-
ment. These indicators were modified for the second
generation MHQIs to include failure to improve in the
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patterns of change for depressive symptoms and cogni-
tive performance. Failure to improve includes any person
who is assessed to have symptoms or functional impair-
ment at initial assessment and whose symptoms or im-
pairment does not change by follow-up. This construct
is considered an adverse outcome similar to an incidence
of symptoms, since the expected trajectory of clinical
status over the course of treatment is improvement.
Thus, the second generation MHQIs measuring change
in clinical status can be defined in two ways: a) improve-
ment and b) incidence or failure to improve. This opera-
tionalization is similar to indicators that have been
defined and validated for nursing home [36], home care
[37,38], and post-acute care sectors [39].
The MHQIs for depressive symptoms and cognitive
performance were calculated within facilities using pa-
tient level data. For depressive symptoms, the denomin-
ator included persons with a score greater than or equal
to 3 on the DSI. This threshold was used because scores
below 3 would indicate very mild depressive symptoms
(less than daily expression of any symptom) that may
not be subject to improvement. For cognitive perform-
ance, the denominator included persons with scores
greater than 0 on the CPS. The numerator for improve-
ment in depressive symptoms or cognitive performance
included all persons whose score on the DSI or CPS was
lower at follow-up compared to the score at initial as-
sessment. For indicators of incidence or failure to im-
prove, the rate included two groups: 1) Persons who had
a score of 0 on either the DSI or CPS at baseline and
whose score was greater at follow-up, or 2) Persons with
baseline scores above 3 on the DSI or above 0 on the
CPS and scores that remained the same or increased at
follow-up. The prevalence of restraint use at the time of
assessment included all persons with a valid assessment
who experienced any one of the three types of restraint
in the three days prior to assessment.
Risk adjustment variable
The RAI-MH System for Classification of Inpatient
Psychiatry (SCIPP), a system recently approved for use
in funding inpatient psychiatry in Ontario [50], was
examined for potential use as a risk adjuster for the
MHQIs. Although it was primarily designed to describe
resource intensity, this additional use of the SCIPP was
inspired by the use of case mix measures for risk adjust-
ment of quality indicators in other health sectors, in-
cluding long term care [36]. The SCIPP uses RAI-MH
items to divide patients into 47 groups based on a hier-
archical grouping of provisional diagnosis and other pa-
tient characteristics (e.g., behaviours, psychotic symptoms).
Each group is assigned a case mix index (SCIPP-CMI)
score ranging from 0.26 to 2.17 representing the relative
cost of caring for patients. A SCIPP-CMI above 1.00
indicates the patient is more resource intensive than the
average patient while SCIPP-CMIs below 1.00 are consid-
ered less resource intensive than the average patient. The
most resource-intensive group includes patients with
schizophrenia, a length of stay less than 3 days, and
observed aggressive behavior. The least resource inten-
sive group includes patients with schizophrenia and
psychotic or affective symptoms present, lengths of stay
of 730 days or more, no indicators of danger to others,
and no difficulties in activities of daily living.
Analysis of MHQIs
Descriptive statistics were calculated for the DSI, CPS,
and restraints items to examine the distribution of these
scales and items in the OMHRS data. The internal
consistency of the DSI was assessed using Chronbach’s
alpha. Convergent validity was assessed by examining
the bivariate odds of having a mood disorder (DSI) or
dementia or other cognitive disorder (CPS) using logistic
regression.
The MHQIs were first developed in the pilot data then
replicated using the OMHRS data. MHQIs rates were
not calculated for facilities with a denominator of less
than 20 patients as these rates would be highly unstable
[51]. The mean, median, and inter-quartile ranges of
MHQI rates among facilities were calculated to describe
the distribution of rates between facilities at a single
point in time. Each MHQI was reviewed based on rea-
sonable variability (e.g., differences of 10%) in the inter-
quartile range between facilities and consistency in rates
above 5% and below 95% for all facilities. Variation in
MHQI scores among facilities was important for the
utility of the MHQI to detect differences in quality.
MHQIs with rates consistently below 5% were consid-
ered not meaningful for quality monitoring given the in-
frequency and rarity of the event among all facilities.
The relationship between the SCIPP CMI and each
MHQI was examined using logistic regression to evalu-
ate the use of the SCIPP CMI in risk adjustment. The
odds ratio and 95% confidence interval was calculated to
determine the strength of relationship between the
SCIPP CMI. Risk adjustment was then performed for
each MHQI in the OMHRS data using the coefficients
from the logistic regression. A predicted MHQI score
for each observation was calculated using the calculated
intercept and SCIPP-CMI regression coefficient, and
each observation’s actual SCIPP-CMI score. The facility
expected MHQI rate was calculated by averaging the
predicted MHQI score of all observations within the fa-
cility. Similar to indirect standardization, the risk
adjusted MHQI rate was calculated by dividing the facil-
ity’s observed MHQI rate by the expected MHQI rate
and multiplying by the observed MHQI rate across all
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facilities. The impact of risk adjustment was assessed by
the relationship between facility rankings on unadjusted
and adjusted MHQI scores using the Spearman rank
order correlation. All analyses were performed using
Statistical Analysis Software version 9.1 (SAS, Cary,
NC).
Results
Table 1 shows selected patient characteristics for the
pilot and OMHRS data. In the pilot data just over half of
patients were under age 45 and had a high school educa-
tion or less, half were male, and most were without a
partner/significant other or spouse. Most patients were
considered acute with just under a third having been ad-
mitted involuntarily. Common DSM-IV diagnoses in-
cluded mood disorders and schizophrenia or other
psychoses. In the OMHRS data, most patients were be-
tween the ages of 25 and 64, about a third were married
or had a partner, half had a mood disorder and just over
a third had schizophrenia or other psychosis.
In the OMHRS data, the distribution of scores on the,
DSI, CPS, and restraint items are found for the total
sample and by diagnostic group in Table 2. The mean
DSI was 3.9 (SD = 3.8) and the median was 3.0. Scores
on the DSI were fairly evenly distributed with 25.6%
(n=8891) of persons having a DSI score of 0 and 27.5%
(n=9570) scored 6 to 15. Regarding convergent validity,
64% (n=12294) of persons scoring 3 or more on the DSI
were found to have a provision diagnosis of mood dis-
order with the odds of having a mood disorder being
2.12 (95% CI = 2.02, 2.2). The DSI was found to have
good internal consistency (Chronbach’s alpha =0.77).
The mean CPS score was 0.8 (SD =1.3) and the median
0.0. About 11% (n=3666) of persons scored 3 or higher
on the CPS, indicating moderate to very severe impair-
ment in cognitive performance. The prevalence of a de-
lirium, dementia, or other cognitive disorder was 27.4%
(n=519) among persons scoring 3 on the CPS (n=1923)
and 42% (n=727) where CPS was greater than 3
(n=1743). The odds of a provisional dementia diagnosis
was 14.2 (95% CI = 13.0, 15.6) among persons where the
CPS was 3 or more. Among all restraints, the most com-
monly used within three days of admission were mech-
anical restraints 4.9% (n=1696). Among the four primary
diagnostic groups represented in Table 2, the highest
prevalence of any restraint use was among persons with
dementia (about 14% to 17%).
Table 3 presents the unadjusted rates and prevalence
among the five MHQIs in the Pilot and OMHRS data.
In the pilot data, the greatest inter-quartile range among
facilities was for the rates of incidence/failure to improve
in cognition (34% difference). In the OMHRS data, im-
provement in cognitive functioning showed the greatest
variation (31% difference). Rates of improvement in
depressive symptoms tended to be higher in the pilot
data compared to OMHRS. Unadjusted prevalence of re-
straint use also varied substantially in both samples, with
facilities in the third quartile having a prevalence of of at
least 14.5% in the pilot data and 10.2% in the OMHRS
data.
Logistic regression results examining the association
between the SCIPP CMI and unadjusted MHQIs can be
Table 1 Characteristics of patients in the pilot and
Ontario Mental Health Reporting System (OMHRS) data
Pilot data OMHRS data
Characteristics N % N %
Age categories
Under 25 220 21% 4085 12%
25-44 365 35% 14190 41%
45-64 332 31% 11775 34%
65+ 139 13% 4725 13%
Gender (male) 540 51% 17349 50%
Marital Status
Never Married 404 38% 16563 48%
Married 253 24% 8941 26%
Partner/significant other 56 5% 1126 3%
Widowed 64 6% 1922 6%
Separated 129 12% 2772 8%
Divorced 141 13% 3464 10%
Education
None 129 12% 1304 4
8th grade or less 62 6% 2369 7
9 – 11 181 17% 6856 20
High school 226 21% 8360 24
Technical/trade school 43 4% 1047 3
Some college/university 162 15% 5975 17
Diploma/Bachelor’s degree 105 10% 3688 11
Graduate degree 31 3% 965 3
Unknown 117 11% 4224 12
Involuntary admission status 296 28% 8772 25%
Patient type:
Acute 764 72% 27627 79%
Longer term 191 18% 4482 13%
Geriatric 80 8% 1527 4%
Forensic 21 2% 1152 3%
Provisional DSM-IV diagnoses:^
Dementia1 130 12% 2353 7%
Mood disorder 570 54% 17884 51%
Psychoses2 415 39% 13058 37%
Substance-related disorder 225 21% 8634 25%
Note: ^ indicates that the percentage of persons with provisional psychiatric
diagnoses may sum to greater than 100% as persons can have more than one
diagnosis. 1Delirium, dementia, and amnestic and other cognitive disorders;
2Schizophrenia and other psychotic disorders.
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Table 2 Frequency of the depression severity index, cognitive performance scale, and restraint items from the RAI-MH for the total OMHRS sample and by
selected primary provisional DSM-IV diagnostic categories
RAI-MH scales and items used
to construct MHQIs
Total Primary provisional DSM-IV diagnostic category
Mood (N=14003) Psychoses1 (N=x11785) Dementia2 (N=1499) Substance3 (N=4479)
Row % N Row % N Row % N Row % N Row % N
Depression Severity Index (DSI)
0 25.56 8891 28.1 2496 47.0 4183 5.8 514 12.8 1142
1-2 19.22 6687 35.1 2346 38.5 2574 4.9 331 13.6 912
3-5 27.71 9640 40.3 3884 33.7 3250 4.5 438 12.7 1229
6-12 27.51 9570 55.1 5277 18.6 1778 2.3 216 12.5 1196
Cognitive Performance Scale (CPS)
0 59.96 20860 44.9 9373 27.8 5798 0.6 122 17.4 3625
1 20.17 7018 37.1 2607 43.7 3064 2.3 159 8.3 583
2 9.33 3244 34.5 1119 44.7 1450 9.2 299 4.6 148
3 5.53 1923 27.4 527 45.4 873 18.1 348 3.9 75
4 0.99 346 22.5 78 47.1 163 17.9 62 2.6 9
5 3.35 1166 21.2 247 33.1 386 34.4 401 3.0 35
6 0.66 231 22.5 52 22.1 51 46.7 108 1.7 4
Restraint Items Column % N Column % N Column % N Column % N
Mechanical restraint 4.9 1696 3.5 491 6.3 740 19.0 285 1.4 61
Chair prevents rising 1.3 414 0.01 75 0.01 66 17.3 259 0.00 6
Physical/manual restraint by staff 3.8 1334 2.7 380 4.8 570 14.7 220 1.4 64
Note: 1 Schizophrenia and other psychotic disorders, 2Delirium, dementia, and amnestic and other cognitive disorders, 3 Substance-related disorders.
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Table 3 Unadjusted and adjusted MHQI rates and prevalence among hospitals in the Pilot data and OMHRS data
Mental Health Quality Indicator PILOT DATA OMHRS DATA
7 Facilities 70 Facilities
Unadjusted facility MHQI rates Unadjusted facility MHQI rates Adjusted facility MHQI rates
Domain Type of indicator Mean % Median % Q1 Q3 Mean % Median % Q1 Q3 Mean % Median % Q1 Q3
Depression Improvement 86.0 88.6 81.3 89.4 74.0 78.9 69.2 83.9 74.0 78.9 69.2 83.8
Incidence/Failure to Improve 12.6 10.4 8.5 15.8 25.0 20.8 17.5 30.2 25.0 20.8 17.5 30.2
Cognitive Performance Improvement 45.7 39.2 37.3 47.9 48.6 49.7 34.7 64.0 48.8 49 34.4 64.1
Incidence/Failure to Improve 34.0 34.5 16.6 50.7 27.0 25.6 17.1 33.2 26.9 25.3 16.7 33.1
Physical Restraint Time 1 Prevalence 8.9 4.2 3.4 14.5 7.8 7.3 3.7 10.2 7.6 7.2 3.6 9.9
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found in Table 4. Higher scores on the SCIPP CMI
were significantly associated with both the improvement
(OR = 1.39, .95CI = 1.29, 1.51) and incidence/failure to
improve (OR = 1.23, .95CI = 1.17, 1.31) in cognitive per-
formance. The mean SCIPP CMI was 1.74 (SD = 0.43)
among persons who improved in cognitive performance
and 1.67 (SD=0.43) among persons who experienced an
incidence or failure to improve in cognitive performance.
The SCIPP CMI was strongly related to the prevalence
of restraint use (OR = 2.71, .95CI = 2.44, 3.01) and was
not associated with MHQIs related to change in depres-
sive symptoms.
Risk adjustment on the SCIPP CMI had little impact
on the MHQI scores among hospitals. Table 3 shows
that the mean, median, and inter-quartile range of un-
adjusted and adjusted MHQIs rates of hospitals in the
OMHRS data did not substantially differ. Among
MHQIs that were significantly predicted by the SCIPP
CMI, adjusted rates were virtually identical across hospi-
tals. The greatest difference in rates was found between
unadjusted (interquartile range of 6.5%) and adjusted
(interquartile range of 6.3%) prevalence of restraints.
Following SCIPP adjustment of the prevalence restraint
use, 34% (n=24) of hospital ranks improved, 36% (n=25)
declined, and 30% (n=21) stayed the same. However, un-
adjusted and adjusted ranks on this indicator were
highly correlated (rSpearman = 0.99, p<0.0001) indicating
that the change in ranks was not substantial. Correla-
tions between ranks on indicators for cognitive perform-
ance and depressive symptoms were 1.0 indicating
virtually no effect of risk adjustment using the SCIPP
CMI.
Discussion
This study has supported the feasibility of the RAI-MH
for developing MHQIs based on three dimensions. How-
ever, the findings point to a need for further validation
and risk adjustment in order for to support ongoing
quality monitoring. The RAI-MH sub-scales used to de-
rive MHQIs for depressive symptoms (the DSI) and cog-
nitive performance (CPS) had acceptable psychometric
properties and variability among persons receiving adult
inpatient mental health services. Unadjusted rate and
prevalence MHQIs derived in this study showed sub-
stantial variation among hospitals in both the pilot and
OMHRS data and no evidence of ceiling or floor effects
were identified. The lower mean rates of improvement
for cognitive performance compared to depressive symp-
toms may be related to the more intensive nature of inter-
ventions for cognitive issues (e.g., occupation rehabilitation)
compared to faster acting interventions (e.g., pharmaceut-
ical) available for management of depressive symptoms.
This finding combined with the variability found among
hospitals within each MHQI supports the potential utility
of the MHQIs for identifying variations in quality. A lack of
variability and consistently high or low rates would indicate
that the MHQIs are not responsive to variations in practice
between hospitals.
The substantial variance in facility MHQI scores, par-
ticularly among indicators measuring changes in cognitive
performance, may also be related to the inherent differ-
ences in the patient case mix among Ontario hospitals.
Evidence was limited for the utility of the SCIPP CMI as
a risk adjuster for the five MHQIs explored in this study.
Conceptually, the SCIPP CMI would seem to be an ap-
propriate risk adjustment variable since it is a composite
measure of diagnosis and patient characteristics that are
organized to produce scores reflecting greater resource
intensity. Since it is used for reimbursement, adjusting
based on the SCIPP CMI would have potential to protect
against inappropriately rewarding or penalizing facilities
for treating either higher or lower risk patients. Although
significant relationships were found between the SCIPP
CMI and MHQIs for cognitive performance and res-
traints, adjustment using the SCIPP CMI led to virtually
no difference between unadjusted and adjusted hospital
MHQI rates or prevalence. The lack of effect in risk ad-
justment may be related to the composition of the SCIPP
CMI. It also suggests that different MHQIs are likely to
require different risk adjusters and that at least some of
these will require more specific, rather than global, mea-
sures of risk. In addition, although SCIPP includes vari-
ables that would be expected to affect risk adjustment
(e.g., diagnosis) the variables that largely drive resource
intensity (e.g., behaviours, suicidality, day of stay, positive
symptoms) are also those that are likely to improve rap-
idly once treatment is initiated. Thus, while they are
related to greater resource utilization at a point in time
they may not be related to the likelihood of good or poor
outcome over time. Instead, case mix adjustment of
MHQIs should focus on the use of singular clinical con-
structs (e.g., items or symptom scales) that impede clinical
efficacy. The broad set of clinical information assessed by
the RAI-MH will be useful for improving the effectiveness
of risk adjustment of MHQIs. Further research is needed
to identify case mix adjusters of MHQIs using variables
representing singular clinical constructs (e.g., items or
symptom scales) rather than composite indices of resource
intensity.
In addition to case mix differences, the variability in
MHQI scores may also reflect differences in care pro-
cesses between hospitals. Detecting such differences is
an important attribute for quality indicators as it links
the measurement of quality to specific opportunities for
quality improvement. The variability in preliminary
MHQI findings between Ontario hospitals could be
related to differences in measurement properties, ascer-
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Table 4 Logistic regression model results for the relationship between the SCIPP CMI and MHQIs based on depressive symptoms, cognitive performance, and
restraint use within three days of admission
95% Confidence interval
Mental Health Quality Indicator Coefficient Standard error p-value Odds ratio Lower Upper
Improvement in depressive symptoms Intercept 1.13 0.06 <0.0001
SCIPP_CMI 0.03 0.03 0.37 1.03 0.96 1.10
Incidence/failure to improve in depressive symptoms Intercept −1.23 0.05 <0.0001
SCIPP_CMI −0.01 0.03 0.83 0.99 0.94 1.05
Improvement in cognitive performance Intercept −0.53 0.07 <0.0001
SCIPP_CMI 0.33 0.04 <0.0001 1.39 1.29 1.51
Incidence/failure to improve in cognitive performance Intercept −1.53 0.05 <0.0001
SCIPP_CMI 0.21 0.03 <0.0001 1.23 1.17 1.31
Prevalence of restraints Intercept −4.32 0.10 <0.0001
SCIPP_CMI 1.00 0.05 <0.0001 2.71 2.44 3.01
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tainment, policy, or practice. Further analysis of the sen-
sitively to change of the RAI-MH scales are needed to
determine if variability in the MHQIs is attributable to
the sensitivity to change of the scales or actual variations
quality. Regarding ascertainment, a thorough training
program for completing the RAI-MH is provided to hos-
pital clinicians by CIHI, “refresher” training may ensure
clinical staff are able to appropriately ascertain clinical
dimensions of these and future MHQIs. Ongoing data
quality monitoring should examine inter-rater reliability
in periodic sub-sample evaluations to identify opportuni-
tiesion for the RAI-MH. Practice issues may be explored
through a comparison between the MHQIs and other
established quality indicators. Once risk adjustment is
improved, establishing a relationship between the MHQIs
and technical process indicators (e.g., staffing levels, use
of evidence based practices, availability of ongoing assess-
ment training, etc.) may identify other contextual factors
related to differences in MHQI scores between facilities.
More importantly, linking the quality indicators to spe-
cific care planning activities may be more effective in
understanding how care processes relate to outcomes.
The RAI-MH includes care planning applications called
Clinical Assessment Protocols (CAPs; formerly Mental
Health Assessment Protocols) [52,53] that identify patient
problems or needs to staff and include a series of guide-
lines that staff can use to intervene if deemed necessary.
Several CAPs may relate to potential domains of out-
come and quality including aggressive behavior and vio-
lence, financial and medication management, activities of
daily living, pain, interpersonal conflict, acute control
medication and physical restraint use. Examining the re-
lationship between use of the CAPs and outcomes based
on the MHQI will be important to further validate the
MHQIs and provide a mechanism for engaging clinical
staff in the quality measurement and improvement pro-
cess directly at the point of care.
The methodology used in this study could be applied to
derivation of MHQIs based on other domains of quality
and outcome. In addition to depressive symptoms, cogni-
tive performance, and restraints, the RAI-MH includes a
number of other domains of symptoms, behaviours, func-
tioning, and safety. For instance, the RAI-MH includes a
positive symptoms scale, pain scale [54], aggressive behav-
ior scale [55], activities of daily living scales [56], and items
measuring social functioning, violent and disruptive be-
havior, financial and medication management, and chem-
ical restraint use are also available [28,41]. Given the
feasibility of the RAI-MH for designing quality indicators,
these dimensions should be explored for the development
of an inventory of RAI-MH MHQIs.
Several limitations of this study should be noted. First,
the pilot data were drawn from only seven facilities that
used the RAI-MH prior to the provincial mandate;
however, the availability of OMHRS data made it
possible to replicate the findings guiding initial MHQI
selection. Second, the MHQIs were derived from data
that excluded patients with stays of less than 6 days and
had only one assessment available. Establishing out-
come MHQIs for these may be limited to prevalence
indicators of events such as self harm, harm to others,
and control procedures. Third, several potential MHQIs
measuring the appropriateness of medication use were
excluded because medication data was unavailable
among all facilities. While all interRAI instruments
include sections on medication use, the OMHRS data
requirements do not include mandated submission of
medication data. Given the importance of pharma-
ceutical therapies as part of psychiatric services, the
lack of these data is an important limitation of the
OMHRS database. Without medication data inferences
cannot be made about differences in quality between
facilities that could be related to the appropriate use of
medications.
The current dichotomy used in the MHQIs to meas-
ure change does not account for the magnitude of
change in a given domain. Indicators assessing magni-
tude of change would complement the MHQIs by pro-
viding information on the clinical efficiency of mental
health services in addition to effectiveness. Research is
currently underway by the authors to examine the sensi-
tivity to change of the RAI-MH sub-scales, including the
DSI and CPS, in order to develop indicators measuring
clinical efficiency based on the magnitude of change in
the MHQI domains over time. In combination, the
MHQIs and efficiency indicators could improve the ac-
curacy of facility rankings by combining information on
the proportion of patients who change with the magni-
tude of that change.
The MHQIs, once validated, carry several advantages
for quality improvement at the person and organization
levels. The MHQIs examined in this study measure
domains that are important for the person’s recovery
process and safety. Supporting improvements in cogni-
tive functioning, for instance, may help the person
achieve and sustain integration back into community
settings. The measurement of such outcomes in ac-
countability frameworks and report cards reinforces
interventions directed at improvement, thus benefiting
patients with such needs. At the organizational level, the
inclusion of improvement as well as incidence/failure to
improve in many MHQI domains emphasizes success
and opportunities for improvement. The use of preva-
lence indicators for restraints emphasizes patient safety.
Combined, these dimensions will be useful for supporting
quality improvement by identifying and sharing best
practices between higher and lower ranking facilities
based on theses and, potentially, other MHQIs.
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Once further refinement is complete, the MHQIs may
also be applicable for quality measurement across health
sectors, from inpatient to community mental health and
beyond. All interRAI instruments include core items
that are consistent across all assessments as well as
items that are specific to the sector being measured [42].
The interRAI Community Mental Health (CMH), for in-
stance, contains 60% of the items used in the RAI-MH.
Only the restraints MHQI cannot be measured using the
interRAI CMH. Completion of the interRAI CMH 30
days after discharge, for instance, could serve as a third
follow-up assessment for inpatient MHQIs and a baseline
assessment for community MHQIs. The interRAI CMH
has been pilot tested in Canada (Ontario, Newfoundland),
Iceland, Cuba, and Chile, but it has not yet been mandated
for regular use.
Conclusions
This study has provided support for the utility of infor-
mation from the RAI-MH for measuring and comparing
quality indicators of process and outcome between facil-
ities. Detailed refinement is needed to fully establish the
reliability and validity of MHQIs based on the RAI-MH.
Prior to this refinement, conclusions about quality care
based on the indicators in their current state may not be
appropriate. Further progress in establishing valid and
reliable MHQIs based on the RAI-MH may identify
outcome indicators that can be used for a number of
important psychiatric domains, including symptom,
functional, behavioral, and safety dimensions. This re-
finement should include additional risk adjustment strat-
egies for the MHQIs to support their use. Once further
refinement is complete, opportunities exist to use the
MHQIs for identifying quality improvement opportun-
ities and comparing quality regionally, nationally, and
internationally, wherever the RAI-MH is used.
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